Search Results 51-60 of 9598 for N-Acetyl Selank

  1. Amjad N. Kanj, M.D., M.P.H.

    Amjad Kanj, M.D., M.P.H., is an Assistant Professor of Medicine at the Mayo Clinic School of Medicine and a board-certified pulmonologist with expertise in ...

  3. Clinical trials - Oncology (Medical)

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  4. Neurosurgery - Clinical trials

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  5. Neurology - Clinical trials - Mayo Clinic

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  6. Neurosurgery - Clinical trials

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  7. https://www.mayoclinic.org/patient_consumer_web.xml

  8. Clinical trials - Oncology (Medical)

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  9. Neurosurgery - Clinical trials

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...

  10. Clinical trials - Oncology (Medical)

    ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring ...